Loading
Please wait while we load your information from QuoteMedia.
Loading
Please wait while we load your information from QuoteMedia.
Please wait while we load your information from QuoteMedia.
Please wait while we load your information from QuoteMedia.
Please wait while we load your information from QuoteMedia.
As of June 4, 2025 • 2:41 PM ET
As of June 4, 2025 • 2:41 PM ET
Date/Time | Source | News Release |
---|---|---|
04/29/2025 04:46 PM EDT | SeekingAlpha | Cannara Biotech Inc. (LOVFF) Q2 2025 Earnings Call Transcript |
04/28/2025 06:20 AM EDT | SeekingAlpha | Cannara Biotech reports Q1 results |
01/27/2025 10:53 AM EST | SeekingAlpha | Cannara Biotech GAAP EPS of C$0.03, revenue of C$25.1M |
07/23/2024 01:38 PM EDT | SeekingAlpha | Cannara Biotech GAAP EPS of C$0.02, revenue of C$19.5M |
04/30/2024 10:07 AM EDT | SeekingAlpha | Cannara Biotech reports Q2 results |
02/08/2024 09:37 AM EST | News Direct | Cannara Biotech CFO Nicholas Sosiak: Unveiling Success Strategies and Future Plans |
07/28/2023 01:30 PM EDT | SeekingAlpha | Cannara Biotech GAAP EPS of C$0.03, revenue of C$15.94M |
04/24/2023 09:29 AM EDT | SeekingAlpha | Cannara Biotech GAAP EPS of -$0.01, revenue of $13M |
01/24/2023 06:30 PM EST | Green Market Report | Daily Hit: January 24, 2023 |
01/24/2023 12:12 PM EST | Green Market Report | Cannara Biotech Expands, But Makes Just $2,200 in Q1 2023 |
Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.